封面
市場調查報告書
商品編碼
1378597

整形外科再生醫學市場:按類型、應用和地區分類

Orthopedic Regenerative Medicine Market, By Type, By Application, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2023年,全球整形外科再生醫學市場將達到95.3億美元,並預計在預測期內(2023-2030年)年複合成長率為10.7%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 95.3億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 10.70% 2030年市場規模預測 193.9億美元
圖 1. 2023 年整形外科再生醫學按應用分類的全球市場佔有率(%)
骨科再生醫學市場-IMG1

整形外科再生醫學是治療方法,整形外科專家使用它來:治療某些整形外科疾病的疼痛和緩解疼痛,例如早期骨關節炎;它可以幫助緩解其他症狀並延遲手術的需要。再生整形外科治療涉及提取、製備人體自然產生的治療化合物並將其注射到需要治療的區域。骨科生物製藥可用於治療退化性疾病,例如某些類型的關節炎,以及運動傷害和創傷。再生醫學使一些患者可以完全避免整形外科手術。再生整形外科可改善肌肉骨骼系統的疼痛和不適,並治癒肌腱、韌帶、骨骼、肌肉、椎間盤、膝半月軟骨、軟骨和其他肌肉骨骼組織損傷等整形外科病症。身體的大部分區域的自癒能力相對較低。再生醫學背後的想法是幫助這些組織更好地癒合。

市場動態

預計主要市場參與者增加的產品推出將在預測期內推動全球整形外科再生醫學市場的成長。例如,2020 年 6 月,商業階段的再生醫學公司 Aziyo Biologics, Inc. 宣布推出其最新的 OsteGro 系列產品,該公司致力於開發下一代差異化產品,改善接受外科手術的患者的治療效果。OsteGro V . OsteGro V 是一種活細胞骨基質,包含鬆質骨顆粒以及去礦物質皮質骨顆粒和纖維,以增強產品處理能力。該產品經過最佳化,可透過 Aziyo Biologics, Inc. 的專有工藝保護和保存天然骨細胞。

本研究的主要特點

  • 本報告對全球整形外科再生醫學市場進行了詳細分析,並提出了以2022年為基準年的預測期(2023-2030年)的市場規模和復合年度(年複合成長率)。
  • 它還強調了各個細分市場的潛在收益成長機會,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數,介紹了全球整形外科再生醫學市場的主要企業。
  • 本研究涵蓋的主要企業包括Anika Therapeutics, Inc.、Arthrex, Inc.、Baxter International, Inc.、CONMED Corporation、Johnson &Johnson、Medtronic, Plc、Smith & Nephew plc、Orthofix、Stryker Corporation、Zimmer Holdings, Inc.、 Aziyo Biologics、Ortho Rgenesis Technologies Inc. 和 OssDsign。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 整形外科再生醫學全球市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球整形外科再生醫學市場的各種策略矩陣來促進決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 合併、收購和合作
  • 法規場景
  • 主要進展
  • PEST分析

第4章 全球整形外科再生醫學市場-新型冠狀病毒感染疾病(COVID-19)的影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 對需求和供給的影響

第5章 2018-2030年全球整形外科再生醫學市場(按類型)

  • 幹細胞
  • 生物材料
  • 人體組織工程

第6章 全球整形外科再生醫學市場,依應用分類,2018-2030

  • 骨關節疾病
  • 類風濕性關節炎
  • 韌帶損傷
  • 黏液囊炎
  • 骨質疏鬆症
  • 其他

第7章 2018-2030年全球整形外科再生醫學市場(按地區)

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第8章 競爭形勢

  • 公司簡介
    • Anika Therapeutics, Inc
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • Johnson &Johnson
    • Medtronic, Plc
    • Smith &Nephew plc
    • Orthofix
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.
    • OssDsign.

第9章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4841

The Global Orthopedic Regenerative Medicine Market is estimated to be valued at US$ 9.53 billion in 2023, and is expected to exhibit a CAGR of 10.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 9.53 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.70% 2030 Value Projection: US$ 19.39 Bn
Figure 1. Global Orthopedic Regenerative Medicine Market Share (%), By Application, 2023
Orthopedic Regenerative Medicine Market - IMG1

Orthopedic regenerative medicine are therapies developed from biologic (natural) substances that can be used by orthopaedic specialists to: Help relieve pain and other symptoms of certain orthopaedic conditions, such as early osteoarthritis, which may help delay the need for surgery. With regenerative orthopedic therapy, healing elements that the body naturally produces are extracted, prepared, and then injected into the areas of the body that need healing, all without drugs or surgery. Orthobiologics can be used to treat degenerative conditions such as certain forms of arthritis, as well as sports injuries and traumas. Regenerative medicine may help some patients avoid orthopedic surgery completely. Regenerative orthopedics may improve pain and discomfort of the musculoskeletal system and enhance the healing of orthopedic conditions, such as injuries of a tendon, ligament, bone, muscle, spinal disc, meniscus of the knee, cartilage or other musculoskeletal tissue. Most of these parts of the body have a relatively poor ability to heal on their own. The idea behind regenerative medicine is to help these tissues heal better.

Market Dynamics

Increasing product launches by the key players in the market are expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, in June 2020, Aziyo Biologics, Inc., a commercial-stage regenerative medicine company creating the next generation of differentiated products to improve outcomes in patients undergoing surgery, announced the launch of its newest OsteGro family product, OsteGro V, a viable cell bone matrix containing cancellous bone particles as well as demineralized cortical bone particles and fibers to enhance product handling. The product is optimized to protect and preserve native bone cells through Aziyo Biologics, Inc.'s proprietary process.

Key features of the study:

  • This report provides an in-depth analysis of the global orthopedic regenerative medicine market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global orthopedic regenerative medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Te key companies covered as a part of this study include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Orthofix, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc., OssDsign
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global orthopedic regenerative medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthopedic regenerative medicine market

Global Orthopedic Regenerative Medicine Market Detailed Segmentation:

  • By Type:
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application:
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Burisitis
    • Osteoporosis
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Anika Therapeutics, Inc
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • Johnson & Johnson
    • Medtronic, Plc
    • Smith & Nephew plc
    • Orthofix
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.
    • OssDsign.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Orthopedic Regenerative Medicine Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Orthopedic Regenerative Medicine Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Stem Cell
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Biomaterial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

6. Global Orthopedic Regenerative Medicine Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Osteoarticular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Rheumatoid Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Ligament Injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Burisitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Osteoporosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global Orthopedic Regenerative Medicine Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Company Profiles
    • Anika Therapeutics, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Arthrex, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Baxter International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • CONMED Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Medtronic, Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Smith & Nephew plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Orthofix
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Stryker Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Zimmer Holdings, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Aziyo Biologics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Ortho Regenerative Technologies Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • OssDsign.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact